Study of Tirzepatide for Recovery and Alcohol Use Management
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT06727331
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Alcohol Use Disorder (AUD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tirzepatide — DRUGThis intervention will consist of the FDA-approved dosing schedule. Participants will receive 2.5mg weekly injections for 4 weeks. IDS will extract tirzepatide and draw the doses into syringes.
- Saline Placebo — OTHERPlacebo syringes of saline and matching volume will be produced by IDS.
Study Details
This is a pilot, 4-week, double-blind, placebo-controlled, randomized trial of individuals with alcohol use disorder (AUD) to receive weekly injections of either tirzepatide (n=10) or matching placebo (n=10). The primary aim is to determine the effects of tirzepatide on cue-reactivity among individuals with AUD. The secondary aim is to assess the safety and preliminary efficacy of tirzepatide for AUD.
Key Dates
- Start date
- Sep 15, 2025
- Status verified
- Dec 2025
- Primary completion
- May 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TirzepatideThis arm will receive tirzepatide (n=10) weekly 2.5mg injections for 4 weeks.
- Placebo Comparator: Saline PlaceboThis arm will receive saline placebo injections (n=10) weekly for 4 weeks.
Primary Outcome Measure
Cue-induced Cravings for Alcohol [ Time Frame: Baseline visit and 5 weeks after baseline visit. ]
Central Contacts
- Joji Suzuki, MD617-732-5752
- Laura M Holsen, Ph.D.617-525-8772
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | - |
| Brigham and Women's Faulkner Hospital | Jamaica Plain | Massachusetts | 02130 | Jeong Hoo (Eric) Lee, MD Joji Suzuki, MD (PRINCIPAL_INVESTIGATOR) Jeong Hoo (Eric) Lee, MD (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Social Identity Mapping for Adolescent RecoveryNot Yet Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Alpha-1 Blockade for Alcohol Use Disorder (AUD)PHASE2 · Recruiting · Brown University · Providence, Rhode Island
- MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive SalienceRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use DisorderPHASE2/PHASE3 · Enrolling By Invitation · University of Pennsylvania · Philadelphia, Pennsylvania